Y-Intercept (HK)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Y-Intercept (HK)’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,308	Closed	-$566K	–	1460
2022 Q3	$566K	Buy	+8,308	New	+$458K	0.06%	483
2022 Q2	–	Sell	-8,245	Closed	-$286K	–	1294
2022 Q1	$286K	Buy	+8,245	New	+$246K	0.07%	467

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Y-Intercept (HK)'s GBT Position: Q4 2022 in Review

Y-Intercept (HK) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 8,308 shares — an estimated $566K sold.

Y-Intercept (HK) first reported a position in GBT in Q1 2022 and held it in 2 quarters. The position peaked at $566K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Y-Intercept (HK) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Y-Intercept (HK) sold 8,308 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $566K.
Y-Intercept (HK) first reported a position in Global Blood Therapeutics, Inc. in Q1 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Global Blood Therapeutics, Inc. position peaked at $566K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Y-Intercept (HK)'s 13F filing for Q4 2022, filed 14 Feb 2023.